NCT03660748View on ClinicalTrials.gov

Safety and Efficacy of MET-3 in Obese Human Subjects

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

January 22, 2020

Study Completion Date

January 22, 2020

Conditions
Obesity
Interventions
BIOLOGICAL

MET-2

Ingestion of a novel human microbiome preparation

Trial Locations (1)

M5C2N8

GI Labs, Toronto

Sponsors

Lead Sponsor

NuBiyota
All Listed Sponsors
collaborator

Glycemic Index Laboratories, Inc

INDUSTRY

lead

NuBiyota

OTHER

NCT03660748 - Safety and Efficacy of MET-3 in Obese Human Subjects | Biotech Hunter | Biotech Hunter